Publication & Citation Trends
Publications
0 total
Abstract 5134: In vitro and in vivo biology characterization of two novel inhibitors targeting the different domains of DNA polymerase theta (Polθ)
Cited by 0
Semantic Scholar
Structures of full-length plasma kallikrein bound to highly specific inhibitors describe a new mode of targeted inhibition. OA
Cited by 13
Semantic Scholar
Structures of human plasma β-factor XIIa cocrystallized with potent inhibitors. OA
Cited by 45
Semantic Scholar
Structure-Guided Design of Novel, Potent, and Selective Macrocyclic Plasma Kallikrein Inhibitors. OA
Cited by 30
Semantic Scholar
Discovery of (R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007): metabolically stable γ-secretase Inhibitor
Cited by 29
Semantic Scholar
Discovery of 4-alkylamino-7-aryl-3-cyanoquinoline LRRK2 kinase inhibitors.
Cited by 32
Semantic Scholar
Selective and Brain‐Permeable Polo‐like Kinase‐2 (Plk‐2) Inhibitors That Reduce α‐Synuclein Phosphorylation in Rat Brain
Cited by 41
Semantic Scholar
Triazolopyridazine LRRK2 kinase inhibitors.
Cited by 29
Semantic Scholar
Novel cinnoline-based inhibitors of LRRK2 kinase activity.
Cited by 34
Semantic Scholar
Research Topics
HIV/AIDS drug development and treatment
(45)
Click Chemistry and Applications
(41)
HIV Research and Treatment
(30)
Chemical Synthesis and Analysis
(30)
Protein Kinase Regulation and GTPase Signaling
(20)
Affiliations
Australian National University
University of Nottingham Ningbo China
University of British Columbia
University of South Florida
Moffitt Cancer Center